BPG is committed to discovery and dissemination of knowledge
Featured Articles
9/10/2020 7:50:29 AM | Browse: 830 | Download: 1375
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 55488
Country Iran
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Review
Article Title Molecular determinants of response to 5-fluorouracil-based chemotherapy in colorectal cancer: The undisputable role of micro-ribonucleic acids
Manuscript Source Invited Manuscript
All Author List Amirsaeed Sabeti Aghabozorgi, Mostafa Moradi Sarabi, Reza Jafarzadeh-Esfehani, Shabnaz Koochakkhani, Marziyeh Hassanzadeh, Soudabeh Kavousipour and Ebrahim Eftekhar
Funding Agency and Grant Number
Corresponding Author Ebrahim Eftekhar, PhD, Associate Professor, Molecular Medicine Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Jomhori Street, Bandar Abbas 7919915519, Iran. eftekhar19@gmail.com
Key Words 5-flurouracil; Colorectal cancer; Chemotherapy resistance; Thymidylate synthase; Microsatellite instability; Micro-ribonucleic acid
Core Tip Resistance to the main chemotherapy drug, 5-flurouracil (5-FU), is an important cause of failure in clinical colorectal cancer (CRC) therapy. Microsatellite instability, increased activity and expression level of thymidylate synthase and dihydropyridine dehydrogenase, mutation of TP53 as well as micro-ribonucleic acids alterations are among the main molecular determinants of response to 5-FU-based chemotherapy in CRC. The identification of potential molecular determinants of response to 5-FU could be an important clinical tool for developing treatment strategies and selecting CRC patients who are most likely to benefit from 5-FU chemotherapy.
Publish Date 2020-09-10 05:57
Citation Sabeti Aghabozorgi A, Moradi Sarabi M, Jafarzadeh-Esfehani R, Koochakkhani S, Hassanzadeh M, Kavousipour S, Eftekhar E. Molecular determinants of response to 5-fluorouracil-based chemotherapy in colorectal cancer: The undisputable role of micro-ribonucleic acids. World J Gastrointest Oncol 2020; 12(9): 942-956
URL https://www.wjgnet.com/1948-5204/full/v12/i9/942.htm
DOI https://dx.doi.org/10.4251/wjgo.v12.i9.942
Full Article (PDF) WJGO-12-942.pdf
Full Article (Word) WJGO-12-942.docx